Price movement over the last 24 hours
ACADIA Pharmaceuticals Inc. vs EPAM Systems Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $25.99 (market cap $4.49B), while EPAM Systems Inc trades at $86.49 (market cap $4.68B). The key difference: ACADIA Pharmaceuticals Inc. and EPAM Systems Inc are close in size by market cap, and ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, EPAM Systems Inc nearer its low. Which is the better fit depends on your goals.
| ACAD | EPAM | |
|---|---|---|
Market Cap | $4.49B | $4.68B |
Sector | Health | Technology |
52-Week High | $28.06 | $221.40 |
52-Week Low | $20.06 | $76.04 |
Enterprise Value | $3.69B | $3.93B |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →EPAM Systems Inc provides software product development and digital platform engineering services to clients located around the world. The company services include Software Product Development, Custom Application Development, Application Testing, Enterprise Application Platforms, Application Maintenance, and Support and Infrastructure Management. The company focuses on innovative and scalable software solutions. The company uses industry standard and custom developed technology, tools, and platforms to deliver results to handle business challenges. The company primarily offers its solutions in the following industries: financial services, travel and consumer, software and hi-tech, life sciences and healthcare. The majority of revenue is generated from North American clients.
Read more on EPAM →